Smart Pill Bottle receives the Good Design Award 2016
![](/46/pdcnewsitem/04/48/25/adheretech.png)
Personal medical device leveraging "Internet of Things" technologies to address medication adherence.
Intelligent Product Solutions (IPS) and AdhereTech have announced that the Smart Pill Bottle received the prestigious Good Design Award 2016. The Good Design award is the world's oldest prize dedicated to the most innovative and cutting-edge industrial products and graphic designs produced around the world.
For the 2016 edition of the Good Design award, the jury evaluated more than 900 candidates from 46 countries, with products spanning a range of sectors, from electronics to robotics, from furnishing to graphics and vehicles.
The AdhereTech Smart Pill Bottle, designed by IPS and AdhereTech, is a personal medical device leveraging "Internet of Things" technologies to address a major problem in the healthcare sector - medication adherence. With the high cost of medication and the health risks of straying from a dosage schedule, patient adherence is paramount to successful care. The AdhereTech Smart Pill Bottle is currently used by leading pharmaceutical companies and pharmacies across the globe.
"We are thrilled that the AdhereTech Smart Pill Bottle was recognized by the Good Design award for its excellence in design, and are very proud of our design work on it," said Mitch Maiman, cofounder and President of IPS. "At IPS, we pride ourselves on our best-in-class design and development of products, and this award further validates our leadership in design."
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance